These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30531116)

  • 1. [Schistosomiasis japonica in a patient who emigrated from China: a case report].
    Machida K; Yamada T; Shimura E; Umemura M; Onoue S; Kaneko M; Mabuchi H; Takahashi Y; Sasada Y; Saida Y
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(12):1094-1100. PubMed ID: 30531116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA detection of Schistosoma japonicum: diagnostic validity of a LAMP assay for low-intensity infection and effects of chemotherapy in humans.
    Xu J; Guan ZX; Zhao B; Wang YY; Cao Y; Zhang HQ; Zhu XQ; He YK; Xia CM
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003668. PubMed ID: 25874964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma japonicum infection in the pig as a model for human schistosomiasis japonica.
    Johansen MV; Bogh HO; Nansen P; Christensen NO
    Acta Trop; 2000 Sep; 76(2):85-99. PubMed ID: 10936567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diagnostic challenge for Schistosomiasis japonica in China: consequences on praziquantel-based morbidity control.
    Zhou YB; Zheng HM; Jiang QW
    Parasit Vectors; 2011 Oct; 4():194. PubMed ID: 21981948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serodiagnosis of Schistosoma japonicum infection: genome-wide identification of a protein marker, and assessment of its diagnostic validity in a field study in China.
    Xu X; Zhang Y; Lin D; Zhang J; Xu J; Liu YM; Hu F; Qing X; Xia C; Pan W
    Lancet Infect Dis; 2014 Jun; 14(6):489-97. PubMed ID: 24656567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of specific antibodies in patients with chronic schistosomiasis japonica by treatment with praziquantel.
    Ohta N; Hosaka Y; Minai M; Hayashi M; Miki Y
    Jpn J Med Sci Biol; 1989 Feb; 42(1):31-8. PubMed ID: 2506387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schistosomiasis japonica of the liver].
    Kawashima T; Sekiya C
    Ryoikibetsu Shokogun Shirizu; 1995; (7):97-9. PubMed ID: 8749426
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience.
    Chen MG
    Acta Trop; 2005; 96(2-3):168-76. PubMed ID: 16125657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical diagnosis of Schistosoma japonicum infection complicating infective endocarditis and liver cirrhosis.
    Yanagisawa S; Yuasa T; Tanaka T
    Intern Med; 2010; 49(11):1001-5. PubMed ID: 20519816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory].
    Liang YS; Li HJ; Dai JR; Wang W; Qu GL; Tao YH; Xing YT; Li YZ; Qian K; Wei JY
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):605-10. PubMed ID: 22379812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical diagnostic value of viable Schistosoma japonicum eggs detected in host tissues.
    Gu K; Li Y; Driguez P; Zeng Q; Yu X; Sun H; Cai L; He Y; Wang W; McManus DP
    BMC Infect Dis; 2017 Apr; 17(1):244. PubMed ID: 28376858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research and control of advanced schistosomiasis japonica in China.
    Wu W; Feng A; Huang Y
    Parasitol Res; 2015 Jan; 114(1):17-27. PubMed ID: 25403379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Schistosoma japonicum to praziquantel in China.
    Liang YS; Dai JR; Ning A; Yu DB; Xu XJ; Zhu YC; Coles GC
    Trop Med Int Health; 2001 Sep; 6(9):707-14. PubMed ID: 11555438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness of the integrated schistosomiasis control strategy with emphasis on infectious source control in China: a 10-year evaluation from 2005 to 2014.
    Wang X; Wang W; Wang P
    Parasitol Res; 2017 Feb; 116(2):521-528. PubMed ID: 27812902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of praziquantel and its optic isomers in experimental therapy of schistosomiasis japonica in rabbits.
    Liu YH; Qian MX; Wang XG; Jia J; Wang QN; Jiang YF; Wang RQ; Yan SH; Chen BY; Li JS
    Chin Med J (Engl); 1986 Dec; 99(12):935-40. PubMed ID: 3105969
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histological observations on schistosomula of Schistosoma japonicum in mouse lung and liver after treatment with praziquantel].
    Yang YQ; Yang HZ; Zhang CW
    Zhongguo Yao Li Xue Bao; 1985 Dec; 6(4):285-7. PubMed ID: 2945377
    [No Abstract]   [Full Text] [Related]  

  • 17. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements.
    Li YS; Sleigh AC; Ross AG; Li Y; Williams GM; Tanner M; McManus DP
    Trans R Soc Trop Med Hyg; 2000; 94(2):191-7. PubMed ID: 10897367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of different isolates of Schistosoma japonicum from China to praziquantel.
    He YX; Hu YQ; Yu QF
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):261-3. PubMed ID: 1439978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China.
    Wang W; Dai JR; Li HJ; Shen XH; Liang YS
    Parasitology; 2010 Nov; 137(13):1905-12. PubMed ID: 20810006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conversion of serum anti-
    Wang LP; Deng WP; Jia TW; Qin ZQ; Xu J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Apr; 33(2):138-147. PubMed ID: 34008360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.